Please login to the form below

Not currently logged in
Email:
Password:

Shingrix

This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.

Shingrix lifts GSK in Q1, but two more vaccines are culled

Shingrix lifts GSK in Q1, but two more vaccines are culled

The decision to drop the two vaccines came as another of GSK’s vaccines – Shingrix for shingles – saw its sales rocket in the first three months of the year, reaching £357m ( ... Shingrix’ performance helped GSK’s vaccine unit to a 23% sales

Latest news

More from news
Approximately 8 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    contain the adjuvant QS-21 Stimulon.  In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.  GSK's malarial vaccine, Mosquirix which also contains

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics